Alphabet’s Isomorphic Labs raises $600 million to advance AI drug design

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and Alphabet, according to the Financial Times. The AI-first drug design and development company plans to utilize the…